HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody

Cancer Immunology, Immunotherapy

Volumn 58, Issue 6, 2009, Pages 967-976

  Wang, Wei ^a   Nishioka, Yasuhiko ^a   Ozaki, Shuji ^a   Jalili, Ali ^a   Abe, Shinji ^b   Kakiuchi, Soji ^a   Kishuku, Masatoshi ^b   Minakuchi, Kazuo ^b   Matsumoto, Toshio ^a   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antibody dependent cellular cytotoxicity; HM1.24 antigen; Immunotherapy; Interferon; Lung cancer

Indexed keywords

CHROMIUM 51; HM1 24 ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HM1 24; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 6; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER TISSUE; CHROMIUM 51 RELEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TARGETING; EXPERIMENTAL NEOPLASM; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

ADENOCARCINOMA; ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOTHERAPY; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; PLEURAL EFFUSION, MALIGNANT; TUMOR CELLS, CULTURED;

EID: 63949083216     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0612-4     Document Type: Article

References (33)

1. PC Hoffman AM Mauer EE Vokes 2000 Lung cancer Lancet 355 479 485
2. SG Spiro GA Silvestri 2005 One hundred years of lung cancer Am J Respir Crit Care Med 172 523 529
3. F Blackhall M Ranson N Thatcher 2006 Where next for gefitinib in patients with lung cancer? Lancet Oncol 7 499 507
4. N Saijo 2006 Recent trends in the treatment of advanced lung cancer Cancer Sci 97 448 452
5. G Egri A Takats 2006 Monoclonal antibodies in the treatment of lung cancer Eur J Surg Oncol 32 385 394
6. A Sandler R Gray MC Perry J Brahmer JH Schiller A Dowlati R Lilenbaum DH Johnson 2006 Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 2542 2550
7. N Hanna R Lilenbaum R Ansari T Lynch R Govindan P Janne P Bonomi 2006 Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer J Clin Oncol 24 5253 5258
8. T Goto SJ Kennel M Abe M Takishita M Kosaka A Solomon S Saito 1994 A novel membrane antigen selectively expressed on terminally differentiated human B cells Blood 84 1922 1930
9. T Ohtomo Y Sugamata Y Ozaki K Ono Y Yoshimura S Kawai Y Koishihara S Ozaki M Kosaka T Hirano M Tsuchiya 1999 Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells Biochem Biophys Res Commun 258 583 591
10. J Ishikawa T Kaisho H Tomizawa BO Lee Y Kobune J Inazawa K Oritani M Itoh T Ochi K Ishihara T Hirano 1995 Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth Genomics 26 527 534
11. S Ozaki M Kosaka S Wakatsuki M Abe Y Koishihara T Matsumoto 1997 Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24 Blood 90 3179 3186
12. A Jalili S Ozaki T Hara H Shibata T Hashimoto M Abe Y Nishioka T Matsumoto 2005 Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma Blood 106 3538 3545
13. M Hundemer S Schmidt M Condomines A Lupu D Hose M Moos F Cremer C Kleist P Terness S Belle AD Ho H Goldschmidt 2006 Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma Exp Hematol 34 486 496
14. J Walter-Yohrling X Cao M Callahan W Weber S Morgenbesser SL Madden C Wang BA Teicher 2003 Identification of genes expressed in malignant cells that promote invasion Cancer Res 63 8939 8947
15. M Becker A Sommer JR Kratzschmar H Seidel H-D Pohlenz I Fichtner 2005 Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM Mol Cancer Ther 4 151 168
16. K Mitani Y Nishioka K Yamabe H Ogawa T Miki H Yanagawa S Sone 2003 Soluble Fas in malignant pleural effusion and its expression in lung cancer cells Cancer Sci 94 302 307
17. Y Nishioka S Yano F Fujiki N Mukaida K Matsushima T Tsuruo S Sone 1997 Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene trasduction: the possibility of immunological overcoming of multidrug resistance Int J Cancer 71 170 177
18. Y Nishioka K Manabe J Kishi W Wang M Inayama M Azuma S Sone 2007 CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages Clin Exp Immunol 149 317 329
19. Y Nishioka M Hirao PD Robbins MT Lotze H Tahara 1999 Induction of systemic and therapeutic antitumor immunity using injection of dendritic cells genetically modified to express interleukin 12 Cancer Res 59 4035 4041
20. M Hanibuchi S Yano Y Nishioka H Yanagawa T Kawano S Sone 1998 Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer cells in NK-depleted SCID mice Int J Cancer 78 480 485
21. P Shrivastava M Hanibuchi S Yano P Parajuli T Tsuruo S Sone 1998 Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporine A or verapamil Cancer Chemother Pharmacol 42 483 490
22. SA Rosenberg 2001 Progress in human tumour immunology and immunotherapy Nature 411 380 384
23. P Weynants B Lethe F Brasseur M Marchand T Boon 1994 Expression of MAGE genes by non-small-cell lung carcinomas Int J Cancer 56 826 829
24. S Shichijo A Hayashi S Takamori R Tsunosue T Hoshino M Sakata T Kuramoto K Oizumi K Itoh 1995 Detection of MAGE-4 protein in lung cancer Int J Cancer 64 158 165
25. JM Wroblewski DL Bixby C Borowski JR Yannelli 2001 Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens Lung Cancer 33 181 194
26. K Tajima Y Obata H Tamaki M Yoshida Y-T Chen MJ Scanlan LJ Old H Kuwano T Takahashi T Takahashi T Mitsudomi 2003 Expression of cancer/testis (CT) antigens in lung cancer Lung Cancer 42 23 33
27. M Sugita M Geraci B Gao RL Powell FR Hirsch G Johnson R Lapadat E Gabrielson R Bremnes PA Bunn WA Franklin 2002 Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung cancer Cancer Res 62 3971 3979
28. M Bolli T Kocher M Adamina U Guller P Dalquen P Haas M Mirlacher F Gambazzi F Harder M Heberer G Sauter GC Spagnoli 2002 Tissue microarray evaluation of melanoma antigen E (MAGE) tumor-associated antigen expression Ann Surg 236 785 793
29. AO Gure R Chua B Williamson M Gonen CA Ferrera S Gnjatic G Ritter AJG Simpson Y-T Chen LJ Old NK Altorki 2005 Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer Clin Cancer Res 11 8055 8062
30. K Imai A Takaoka 2006 Comparing antibody and small-molecule therapies for cancer Nature 6 714 727
31. GP Adams LM Weiner 2005 Monoclonal antibody therapy of caner Nature Biotechnol 23 1147 1157
32. A Matsuda Y Suzuki G Honda S Muramatsu O Matsuzaki Y Nagano T Doi K Shimotohno T Harada E Nishida H Hayashi S Sugano 2003 Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways Oncogene 22 3307 3318
33. M Vidal-Laliena X Romero S March V Requena J Petriz P Engel 2005 Characterization of antibodies submitted to the B cell section of the 8th human leukocyte deifferentiation antigens workshop by flow cytometory and immunohistochemistry Cell Immunol 236 6 16